Overview

Pilot Study to Investigate a Steroid Free Immunosuppressive Regimen for Renal Transplant Recipients

Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
0
Participant gender:
All
Summary
The main purpose of this study is to investigate, whether a steroid free immunosuppressive treatment is a valuable alternative in the treatment of de novo kidney transplant recipients and if it is possible to withdraw calcineurin inhibitors after 3 months.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
University Hospital, Basel, Switzerland
Treatments:
Calcineurin Inhibitors
Everolimus
Immunosuppressive Agents
Sirolimus
Tacrolimus
Criteria
Inclusion Criteria:

- adult patients with end stage kidney disease suitable for primary renal
transplantation or retransplantation

- patients receiving a graft from a living related, living unrelated or brain-death
donor

Exclusion Criteria:

- patients with a low or high immunological risk constellation